Clinical Trials Logo
  1. Home
  2. H1N1 Influenza
  3. NCT01798602

Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial — CHAT Pilot  

H1N1 Influenza Clinical Trial

Official title:
Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial

Clinical Trial Summary

The CHAT Pilot Trial is designed to compare rosuvastatin against placebo in patients with suspected H1N1. The pilot study will assess the feasibility of our clinical protocols, and study procedures.

Clinical Trial Description

This trial is a pilot study to assess the feasibility and acceptability of a double blind randomized controlled trial (RCT) evaluating the efficacy of rosuvastatin as adjuvant therapy for H1N1 influenza ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01798602
Study type Interventional
Source Canadian Critical Care Trials Group
Contact
Status Terminated
Phase Phase 2
Start date December 2009
Completion date August 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT03641690 - Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
Terminated NCT00970606 - STIP: Statin Trial for Influenza Patients N/A
Completed NCT02921997 - H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses Phase 2
Recruiting NCT01008683 - Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation N/A
Completed NCT01011582 - Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza N/A
Active, not recruiting NCT01421251 - H1N1 Vaccine Safety in Manitoba, Canada N/A
Recruiting NCT04497311 - Tomographic Findings in COVID-19 and Influenza
Completed NCT04933994 - Comparison of COVID-19 and H1N1 Influenza Pneumonia
Completed NCT01002040 - Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV Phase 4
Unknown status NCT01127282 - The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Phase 4
Terminated NCT04810949 - Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml N/A
Completed NCT05080933 - ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS